BioMarin Pharmaceutical Inc. (BMRN) Should See Upside From Valrox Breaking $1M Pricing Barrier - SVB Leerink
Tweet Send to a Friend
SVB Leerink analyst Joseph Schwartz reiterated an Outperform rating on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) after Zolgensma breaks the $1M ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
